GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Center Laboratories Inc (ROCO:4123) » Definitions » Liabilities-to-Assets

Center Laboratories (ROCO:4123) Liabilities-to-Assets : 0.27 (As of Mar. 2025)


View and export this data going back to 2003. Start your Free Trial

What is Center Laboratories Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Center Laboratories's Total Liabilities for the quarter that ended in Mar. 2025 was NT$6,925 Mil. Center Laboratories's Total Assets for the quarter that ended in Mar. 2025 was NT$25,553 Mil. Therefore, Center Laboratories's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2025 was 0.27.


Center Laboratories Liabilities-to-Assets Historical Data

The historical data trend for Center Laboratories's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Center Laboratories Liabilities-to-Assets Chart

Center Laboratories Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.31 0.24 0.25 0.29

Center Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.31 0.26 0.29 0.27

Competitive Comparison of Center Laboratories's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Center Laboratories's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Center Laboratories's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Center Laboratories's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Center Laboratories's Liabilities-to-Assets falls into.


;
;

Center Laboratories Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Center Laboratories's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

Liabilities-to-Assets (A: Dec. 2024 )=Total Liabilities/Total Assets
=7482.692/25537.175
=0.29

Center Laboratories's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2025 is calculated as

Liabilities-to-Assets (Q: Mar. 2025 )=Total Liabilities/Total Assets
=6925.491/25553.232
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Center Laboratories  (ROCO:4123) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Center Laboratories Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Center Laboratories's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Center Laboratories Business Description

Traded in Other Exchanges
N/A
Address
No. 3-2, Park Street, 7th floor, Nangang District, Taipei, TWN
Center Laboratories Inc is active in the healthcare sector. The company is engaged in the manufacture and sale of various Western medicines. The segments include: Pharmaceutical Division which includes manufacturing and sales of various Western Medicines; Biotechnology Venture Capital consists Investing in domestic and foreign biotechnology undertakings; Glac segment - Manufacture and sale of probiotic products and others. It geographically operates in Taiwan, China and Others.

Center Laboratories Headlines

No Headlines